FIELD: medicine.
SUBSTANCE: invention refers to pharmaceutical composition for prevention and treatment of neurodegenerative diseases, containing 3-(2-cyanophenyl)-1-phenyl-5-(2-pyridyl)-1,2-dihydropyridine-2-one, its salt or hydrate and interferon-beta, a combination containing 3-(2-cyanophenyl)-1-phenyl-5-(2-pyridyl)-1,2-dihydropyridine-2-one, its salt or hydrate and interferon-beta, and therapy of neurodegenerative diseases applying thereof.
EFFECT: high clinical effectiveness.
23 cl, 2 dwg, 3 tbl, 404 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 1,2-DIHYDROPYRIDINE COMPOUNDS, METHOD FOR THEIR PREPARING AND THEIR USING | 2001 |
|
RU2265015C2 |
| DERIVATIVES OF PYRIDAZINONE AND TRIAZINONE AND THEIR USING AS PHARMACEUTICAL PREPARATIONS | 2001 |
|
RU2279428C2 |
| COMPOUND, PHARMACEUTICAL COMPOSITION, APPLYING, METHOD FOR PROPHYLAXIS AND TREATMENT OF DISEASE | 2002 |
|
RU2256652C1 |
| AMIDES OF CONDENSED PIPERIDINE AS MODULATORS OF ION CHANNELS | 2014 |
|
RU2741810C2 |
| CONDENSED 4-OXOPYRIMIDINE DERIVATIVE | 2005 |
|
RU2358969C2 |
| PYRIDOINDOLONE DERIVATIVES SUBSTITUTED IN POSITION 6, THEIR OBTAINING AND APPLICATION IN THERAPY | 2005 |
|
RU2364595C2 |
| HETEROCYCLIC COMPOUNDS AND USE THEREOF IN TREATING OR PREVENTING BACTERIAL INFECTIONS | 2016 |
|
RU2741496C2 |
| NEW DERIVATIVE OF 3-AZABICYCLO[3.1.0]HEXANE AND USE THEREOF FOR MEDICAL PURPOSES | 2014 |
|
RU2701861C1 |
| PROTEIN KINASE INHIBITORS FOR ENHANCING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH | 2019 |
|
RU2822216C2 |
| DERIVATIVES OF DIPHENYL, DERIVATIVE OF PHENYLPIPERAZINE, METHOD OF PATIENTS TREATMENT | 1995 |
|
RU2125051C1 |
